A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Clinical trial NCT04307576 · RECRUITING
Trial details
- NCT number
- NCT04307576
- Sponsor
- Mats Heyman
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2033-06-01
- Enrollment
- 6430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.